:covid-19: Monoclonal Antibody (MAB) Therapeutic Sotrovimab
Contract Overview
Contract Amount: $279,862,800 ($279.9M)
Contractor: Glaxosmithkline, LLC
Awarding Agency: Department of Defense
Start Date: 2021-09-24
End Date: 2022-05-19
Contract Duration: 237 days
Daily Burn Rate: $1.2M/day
Official Description: :COVID-19: MONOCLONAL ANTIBODY (MAB) THERAPEUTIC SOTROVIMAB
Place of Performance
Location: North Carolina, 27709